Author Correction: Osteosarcoma
Nat Rev Dis Primers
.
2022 Dec 30;8(1):82.
doi: 10.1038/s41572-022-00416-z.
Authors
Hannah C Beird
1
,
Stefan S Bielack
2
,
Adrienne M Flanagan
3
,
Jonathan Gill
4
,
Dominique Heymann
5
,
Katherine A Janeway
6
,
J Andrew Livingston
7
,
Ryan D Roberts
8
,
Sandra J Strauss
9
,
Richard Gorlick
10
11
Affiliations
1
Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
2
Pediatric Oncology, Hematology, Immunology, Klinikum Stuttgart - Olgahospital, Stuttgart Cancer Center, Stuttgart, Germany.
3
Research Department of Pathology, Cancer Institute, University College London, London, UK.
4
Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
5
Nantes Université, CNRS, UMR6286, US2B, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.
6
Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.
7
Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
8
Center for Childhood Cancer, Nationwide Children's Hospital, Columbus, Ohio, USA.
9
University College London Hospitals NHS Foundation Trust, University College London, London, UK.
10
Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. rgorlick@mdanderson.org.
11
Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. rgorlick@mdanderson.org.
PMID:
36585406
DOI:
10.1038/s41572-022-00416-z
No abstract available
Publication types
Published Erratum